This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eichenfield, L. F.
Right arrow Articles by Cunningham, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eichenfield, L. F.
Right arrow Articles by Cunningham, B. B.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 109 No. 6 June 2002, pp. 1093-1099

A Clinical Study to Evaluate the Efficacy of ELA-Max (4% Liposomal Lidocaine) as Compared With Eutectic Mixture of Local Anesthetics Cream for Pain Reduction of Venipuncture in Children

Lawrence F. Eichenfield, MD, Ann Funk, RN, Sheila Fallon-Friedlander, MD and Bari B. Cunningham, MD

From the Division of Pediatric and Adolescent Dermatology, Children’s Hospital, San Diego, and Departments of Pediatrics and Medicine, University of California, San Diego School of Medicine, San Diego, California

--> Objective. A double-randomized, blinded crossover trial was performed to assess the efficacy of ELA-Max (4% liposomal lidocaine) as compared with eutectic mixture of local anesthetics (EMLA) for pain relief during pediatric venipuncture procedures. Safety was assessed by evaluation for topical or systemic effects and measurement of serum lidocaine concentrations.

Methods. A total of 120 children who were scheduled for repeat venipuncture for non–study-related reasons at 2 sites participated in the study. Patients were doubly randomized to treatment regimen (study medication application time of either 30 or 60 minutes) and to the order of application of the topical anesthetics for each venipuncture. The primary outcome measures were the child’s rating of pain immediately after the venipuncture procedures using a 100-mm visual analog scale (VAS) tool and the parent’s and blinded research observer’s Observed Behavioral Distress scores.

Results. Both ELA-Max and EMLA seemed to alleviate venipuncture pain. There was no clinically or statistically significant difference in the patient VAS scores within the 30-minute or 60-minute treatment groups, and there was no clinical or statistical difference in VAS scores between the 30-minute ELA-Max treatment without occlusion and the 60-minute EMLA treatment with occlusion. There were no clinically or statistically significant differences between treatment with ELA-Max and EMLA in parental or blinded researcher Observed Behavioral Distress scores, the most frequent response at any observation time being "no distress."

Conclusion. This study demonstrates that a 30-minute application of ELA-Max without occlusion is as safe and as effective for ameliorating pain associated with venipuncture as a 60-minute application of the prescription product EMLA requiring occlusion.

Key Words: topical anesthesia • liposomal lidocaine • pain • eutectic mixture of local anesthetics

Abbreviations: EMLA, eutectic mixture of local anesthetics • VAS, visual analog scale • OBD, Observed Behavioral Distress • SD, standard deviation


Received for publication Aug 15, 2001; Accepted .


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
B. A. Howell and A. Chauhan
Bupivacaine Binding to Pegylated Liposomes
Anesth. Analg., August 1, 2009; 109(2): 678 - 682.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
W. T. Zempsky
Pharmacologic Approaches for Reducing Venous Access Pain in Children
Pediatrics, November 1, 2008; 122(Supplement_3): S140 - S153.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. Leahy, R. M. Kennedy, J. Hesselgrave, K. Gurwitch, M. Barkey, and T. F. Millar
On the Front Lines: Lessons Learned in Implementing Multidisciplinary Peripheral Venous Access Pain-Management Programs in Pediatric Hospitals
Pediatrics, November 1, 2008; 122(Supplement_3): S161 - S170.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
J. Pershad, S. C. Steinberg, and T. M. Waters
Cost-effectiveness Analysis of Anesthetic Agents During Peripheral Intravenous Cannulation in the Pediatric Emergency Department
Arch Pediatr Adolesc Med, October 1, 2008; 162(10): 952 - 961.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
W. T. Zempsky, J. Bean-Lijewski, R. E. Kauffman, J. L. Koh, S. V. Malviya, J. B. Rose, P. T. Richards, and D. J. Gennevois
Needle-Free Powder Lidocaine Delivery System Provides Rapid Effective Analgesia for Venipuncture or Cannulation Pain in Children: Randomized, Double-Blind Comparison of Venipuncture and Venous Cannulation Pain After Fast-Onset Needle-Free Powder Lidocaine or Placebo Treatment Trial
Pediatrics, May 1, 2008; 121(5): 979 - 987.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
R. Cregin, A. S Rappaport, G. Montagnino, G. Sabogal, H. Moreau, and J. J. Abularrage
Improving pain management for pediatric patients undergoing nonurgent painful procedures
Am. J. Health Syst. Pharm., April 15, 2008; 65(8): 723 - 727.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Franz-Montan, A. L. R. Silva, K. Cogo, C. d. C. Bergamaschi, M. C. Volpato, J. Ranali, E. de Paula, and F. C. Groppo
Liposome-Encapsulated Ropivacaine for Topical Anesthesia of Human Oral Mucosa
Anesth. Analg., June 1, 2007; 104(6): 1528 - 1531.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
N. L. Schechter, W. T. Zempsky, L. L. Cohen, P. J. McGrath, C. M. McMurtry, and N. S. Bright
Pain Reduction During Pediatric Immunizations: Evidence-Based Review and Recommendations
Pediatrics, May 1, 2007; 119(5): e1184 - e1198.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
American Academy of Pediatrics, American Academy of Pediatric Dentistry, C. J. Cote, S. Wilson, and the Work Group on Sedation
Guidelines for Monitoring and Management of Pediatric Patients During and After Sedation for Diagnostic and Therapeutic Procedures: An Update
Pediatrics, December 1, 2006; 118(6): 2587 - 2602.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
C V Bellieni, D M Cordelli, M Raffaelli, B Ricci, G Morgese, and G Buonocore
Analgesic effect of watching TV during venipuncture
Arch. Dis. Child., December 1, 2006; 91(12): 1015 - 1017.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
P. J. Sharek, R. Powers, A. Koehn, and K. J.S. Anand
Evaluation and Development of Potentially Better Practices to Improve Pain Management of Neonates
Pediatrics, November 1, 2006; 118(Supplement_2): S78 - S86.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
C. V. Fernandez and G. Frager
Reducing procedural pain
Can. Med. Assoc. J., January 17, 2006; 174(2): 206 - 206.
[Full Text] [PDF]


Home page
CMAJHome page
A. Taddio, H. K. Soin, S. Schuh, G. Koren, and D. Scolnik
Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial
Can. Med. Assoc. J., June 21, 2005; 172(13): 1691 - 1695.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. Migdal, E. Chudzynska-Pomianowska, E. Vause, E. Henry, and J. Lazar
Rapid, Needle-Free Delivery of Lidocaine for Reducing the Pain of Venipuncture Among Pediatric Subjects
Pediatrics, April 1, 2005; 115(4): e393 - e398.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
O Quaba, J S Huntley, H Bahia, and D W McKeown
A users guide for reducing the pain of local anaesthetic administration
Emerg. Med. J., March 1, 2005; 22(3): 188 - 189.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
W. T. Zempsky, J. P. Cravero, and Committee on Pediatric Emergency Medicine, and Sec
Relief of Pain and Anxiety in Pediatric Patients in Emergency Medical Systems
Pediatrics, November 1, 2004; 114(5): 1348 - 1356.
[Abstract] [Full Text] [PDF]


Home page
AAP NewsHome page
C. S. Houck
Taking `ouch' out of doctor visits easier than ever
AAP News, August 1, 2004; 25(2): 66 - 66.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. Hefler, C. Grimm, S. Leodolter, and C. Tempfer
To Butterfly or To Needle: The Pilot Phase
Ann Intern Med, June 1, 2004; 140(11): 935 - 936.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
R. D Goldman
ELA-max: A New Topical Lidocaine Formulation
Ann. Pharmacother., May 1, 2004; 38(5): 892 - 894.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Luhmann, S. Hurt, M. Shootman, and R. Kennedy
A Comparison of Buffered Lidocaine Versus ELA-Max Before Peripheral Intravenous Catheter Insertions in Children
Pediatrics, March 1, 2004; 113(3): e217 - 220.
[Abstract] [Full Text] [PDF]